Although apparently phenotypically normal at birth, mice heterozygous for inactivation of the gene encoding parathyroid hormone-related peptide (PTHrP) develop haplotype insufficiency by 3 months of age. In addition to histologic and morphologic abnormalities similar to those seen in homozygous mutants, heterozygous animals demonstrated alterations in trabecular bone and bone marrow. These included metaphyseal bone spicules which were diminished in volume, irregularly distributed, and less well developed than those seen in age-matched controls as well as bone marrow, which contained an inordinate number of adipocytes. A substantial reduction in PTHrP mRNA was detected in heterozygous tissue, while circulating parathyroid hormone (PTH) and calcium concentrations were normal. Thus, while a physiologic concentration of PTH was capable of maintaining calcium homeostasis, it was incapable of compensating for PTHrP haploinsufficiency in developing bone. In normal animals, both PTHrP and the PTH/PTHrP receptor were expressed predominantly in chondrocytes situated throughout the proliferative zone of the tibial growth plate. In the metaphysis, the PTH/PTHrP receptor was identified on osteoblasts and preosteoblastic cells situated in the bone marrow, while PTHrP was expressed only by osteoblasts. These observations indicate that postnatal bone development involves susceptible pathways that display exquisite sensitivity to critical levels of PTHrP and imply that the skeletal effects of PTH are influenced by locally produced PTHrP. Moreover, identification of both the ligand and its N-terminal receptor in metaphyseal osteoblasts and their progenitors suggests an autocrine/paracrine role for the protein in osteoblast differentiation and/or function. Impairment in this function as a consequence of PTHrP haploinsufficiency may critically influence the course of bone formation, resulting in altered trabecular architecture and perhaps low bone mass and increased bone fragility. ᭧
INTRODUCTION
. The sequences of cDNAs and genes encoding this peptide have been determined (Mangin et al., Parathyroid hormone-related peptide (PTHrP) 1 is an onco-1988; Yasuda et al., 1989a,b; Karaplis et al., 1990) . The hoprotein involved in the pathogenesis of malignancy-associmology in the NH 2 -terminal region of parathyroid hormone ated hypercalcemia (Strewler et al., 1987; Burtis et al., 1987;  (PTH) and PTHrP facilitates their interaction at a common target tissue receptor (Jü ppner et al., 1991; Abou-Samra et al., 1992) and results in similar activities with respect to 1 Abbreviations used: PTHrP, parathyroid hormone-related pepbone metabolism and systemic calcium homeostasis (Rotide; PTH, parathyroid hormone; RT-PCR, reverse transcriptase- dan et al., 1983; Horiuchi et al., 1987; Kemp et al., 1987;  polymerase chain reaction; SEM, scanning electron microscopy; Rabbani et al., 1988; Thompson et al., 1988) Unlike PTH, TEM, transmission electron microscopy; ALPase, alkaline phosphatase; PT cell, parathyroid hormone target cell.
whose expression is localized to parathyroid cells, PTHrP perScript II RNase H-reverse transcriptase (Gibco BRL, Gaithers- is produced in various normal cells and tissues, including burg, MD).
keratinocytes, heart, smooth muscle, many endocrine cells, Quantitative PCR was then applied to precisely determine the and lactating mammary glands (Merendino et al., 1986;  amount of glyceraldehyde-6-phosphate dehydrogenase (GAPDH) Thiede and Rodan, 1988; Thiede et al., 1990; Drucker et transcripts in each sample as described previously (Lipman et al., al., 1989; Kramer et al., 1991; Deftos et al., 1993) . In parallel 1994). Subsequently, PCR was performed to amplify PTHrP tranwith the broad distribution of PTHrP, the PTH/PTHrP rescripts using the dilutions of normal (cDNA/competitive template ceptor has been reported to be widespread in various tissues (c.t.) of 1.0) and heterozygote cDNA (cDNA/c.t. of 1.0) that had (Ureñ a et al., 1993) , despite the fact that it had previously been shown by densitometric scanning to contain equal amounts been considered to be localized only to the classical PTH of GAPDH transcripts. Sense (OC1: 5-GCT GTG TCT GAA CAT CAG CTA CT-3 ) and antisense (OC2: 5-GAT CCC AAT GCA target tissues of bone and kidney. This widespread distribu-TTT ACA GTA TG-3 ) primers were used to amplify the endogetion of ligand and receptor suggests that PTHrP may act in nous 531-bp PTHrP fragment. The thermal cycling parameters conan autocrine and/or paracrine mode  sisted of denaturing at 94ЊC for 1 min, annealing at 54ЊC for 1 Orloff et al., 1989) . Evidence to support such a mechanism min, and extension at 72ЊC for 1 min for 35 cycles. Ten-microliter of action has been provided by studies with antisense inhibireaction aliquots were electrophoresed on a 2% agarose gel and tion of PTHrP synthesis in vitro (Kaiser et al., 1992 (Kaiser et al., , 1994 , visualized by ethidium bromide staining.
by experiments in transgenic mice which overexpress PTHrP Vasavada et al., 1994) , and by studies of PTHrP gene inactivation in mice via ho-
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mologous recombination (Karaplis et al., 1994; Amizuka et al., 1994) . All these approaches have provided evidence for a role for PTHrP in normal cell proliferation and differentia- abnormalities and altered endochondral bone formation in these animals (Karaplis et al., 1994; Amizuka et al., 1994) that culminate in their death in the immediate peripartum 
Concentrations

Histological and Ultrastructural Analyses
MATERIALS AND METHODS
20 kV. Specimens for light and transmission electron microscopy (TEM) were processed as described previously (Warshawsky and Moore, 1967) .
Generation of Mice Heterozygous for PTHrP Gene Inactivation
Mice carrying a null mutation of the PTHrP gene were generated
Histomorphometric Analysis
using the technique of homologous recombination (Karaplis et al., 1994) . Wild-type litter mates and fetuses heterozygous for the muFor histomorphometric analysis, 3-month-old mice heterozygous tation were identified by Southern blot analysis of genomic DNA (//0) for ablation of the PTHrP gene and wild-type (///) litand used for subsequent analysis. For staining and visualization of termates were injected intraperitoneally with 10 mg/100 g body skeletons, mice were dissected and stained with alizarin red S, as weight calcein (Wako Pure Chemicals, Osaka, Japan) and sacrificed previously described (Karaplis et al., 1994) .
by cervical dislocation 24 hr later. Tibiae were cleaned and kept in 70% ethanol for 5 days at 4ЊC, stained according to Villaneuva (1974; Villanueva and Lundin, 1989) and dehydrated in graded ethanol prior to embedding in methyl methacrylate (Wako). Polymer-
Reverse Transcriptase-Polymerase Chain Reaction
ized blocks were ground to the midpoint of the longitudinal axis (RT-PCR) for PTHrP and analyzed using a confocal laser-scanning microscope (LSM-GB200; Olympus, Tokyo, Japan) and a Hewlett Packard Vecta 396/ Kidneys from 3-month-old wild-type (///) and heterozygous (//0) litter mates were snap-frozen and total RNA was extracted 25 equipped with GB200 3D imaging software. The number (TbN/ mm 2 ) of trabeculae as well as the trabecular volume [BV/TV(%)] from 20 mg of tissue using the RNeasy Total RNA kit (Qiagen, Chatsworth, CA). For first-strand cDNA synthesis, 5 mg of total was measured in the tibial metaphysis of eight wild-type and seven heterozygous animals. Statistical analysis was by Student's t test. RNA was primed with oligo(dT) and reverse transcribed using Su-A hybridization mixture composed of 50% formamide, 10 mM
Radioautographic Studies
Tris -HCl, pH 7.6, 100 mg tRNA, 11 Denhardt's solution, 10% Chondrocyte proliferation was evaluated in vivo using [ 3 H]-dextran sulfate, 600 mM NaCl, 0.25% SDS, and 1 mM EDTA was thymidine labeling as described previously (Amizuka et al., 1994) . preheated for 10 min at 90ЊC. cRNAs were adjusted to a concentraIn vivo binding studies using iodinated PTH and PTHrP were pertion of 0.1-1.0 mg/ml (determined by the protocol of Boehringer formed as previously reported (Rouleau et al., , 1988 (Rouleau et al., , 1990 . Mannheim) and denatured by heating at 90ЊC for 2-3 min before Synthetic [Tyr 36 ] PTHrP (1 -36)-NH2 (Peninsula Laboratories, Belapplying to the sections. After hybridizing overnight at 50ЊC, secmont, CA) and PTH (1 -34) (Bachem Corp., Torrance, CA) were tions were washed with 50% formamide in 21 SSC at 50 -55ЊC for labeled with 125 I to a specific activity of 300 mCi/mg using the lacto-30 min and treated at 37ЊC with a solution of 10 mM Tris -HCl peroxidase technique (DeMay et al., 1985) .
125
I-labeled peptides (pH 8.0), 0.5 M NaCl, and 1 mM EDTA (TNE). Non-specific binding were injected either alone (experimental animals) or with a 500-of probes was reduced by RNase A treatment (20 mg/ml in TNE fold excess of unlabeled hormone (control animals). solution) at 37ЊC for 30 min. Digoxigenin-labeled sections were preincubated with 2% blocking agent and incubated for 45 -60 min with alkaline phosphatase-conjugated sheep anti-digoxigenin antibody at a dilution of Immunocytochemistry for PTHrP, Type II 1:1000. Visualization was achieved using nitroblue tetrazolium salt
Collagen, and Chondroitin Sulfate
and 5-bromo-4-chloro-3-indolyl phosphate. Anesthetized normal mice were perfused with a solution of 2%
For double-labeled in situ hybridization, radioactive sense and paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 10 min.
antisense cRNA probes for the PTH/PTHrP receptor were prepared Femora and tibiae were then dissected free and additionally fixed from the cloned cDNA using [ 35 S]UTP (Amersham Canada, Oakin the same solution for 4 hr at 4ЊC. Specimens were decalcified ville, ON). Digoxigenin-labeled probes, prepared as described above, in 10% EDTA for 1 week, embedded in OCT compound, and frozen were used for PTHrP. After reduction of the average probe length by immersion in liquid nitrogen. Cryostat sections (10 mm thick) to 300 bases, radioactive antisense probes (5 -10 1 104 cpm/ml) were collected on poly-L-lysine-coated glass slides (Polyscience and digoxigenin-labeled probes were added together in the same Inc., Warrington, PA) and then treated with a mixture of 95% methhybridization mixture. Sections were then incubated with the hyanol and 0.3% H 2 O 2 for 30 min to inhibit endogenous peroxidase.
bridization mixture as described above. Immunodetection of digoxPTHrP immunocytochemistry was performed as described preigenin-labeled probes was performed, as described above, prior to viously (Amizuka et al., 1994) using polyclonal antisera raised detection of radioactivity by radioautography. For radioautography, against synthetic PTHrP (1 -34) (17, 36) or PTHrP (87-110). Type sections were dipped in Kodak NTB-2 liquid emulsion and exposed II collagen and chondroitin sulfate immunocytochemistry were for 2 weeks in the dark at 4ЊC. Sense probes were used as controls. performed on longitudinal frozen sections of femora and tibiae of wild-type and heterozygous littermates as previously described (Amizuka et al., 1994) .
RESULTS
Gross Morphology and Molecular and Biochemical In Situ Hybridization of PTHrP, PTH/PTHrP
Characteristics of Heterozygous Mice Receptor, and Alkaline Phosphatase (ALPase) bones of these animals histologically for further evidence of haploinsufficiency. Using SEM, the three-dimensional structure of the femur of a 3-month-old heterozygote (Fig.  2B ) was compared with that of its wild-type littermate ( Fig.  2A) . Although the overall size of the distal portion of these bones was similar, the epiphyseal head was smaller and the epiphyseal cartilage reduced in size in the heterozygotes. In the metaphysis of the wild-type mouse, bone spicules were of uniform size and extended parallel to the longitudinal axis, whereas those of the heterozygote were not oriented longitudinally and were of variable thickness and length. These alterations were prominent in 3-month-old heterozygotes but of minor consequence in 1.5-month-old mice. There were no apparent abnormalities in cortical bone at either time point.
Longitudinal histological sections (Figs. 2C and 2D) of tibiae and femora from heterozygous mice revealed fewer mixed spicules, which also had an abnormal orientation, in metaphyseal bone. In addition, an inordinate number of adipocytes were observed in the bone marrow of these 3-month-old mice compared with that in their wild-type litter mates (compare Figs. 2C and 2D ). Nonmarrow cells in the intertrabecular regions occasionally also contained lipid droplets. At 1.5 months there were fewer adipocytes in the marrow and lipid droplets were not seen in nonmarrow cells in this region.
In the growth plate of the heterozygotes, clusters of chondrocytes disrupting the orderly columns were often observed (compare Figs. 2E and 2F ), resulting in distortion of the longitudinal cartilage partitions. This local failure of chondrocytes to assemble the correct cartilage matrix archi- nostaining for type II collagen and chondroitin sulfate
The molecular weight marker is a fX174DNA-HaeIII digest.
showed similar patterns of distribution in normal and heterozygous animals, as did in situ hybridization for ALPase mRNA (data not shown).
As shown in Fig. 3 , histomorphometric analysis of the transcripts, heterozygous mice displayed normal concentrations of plasma calcium (1.94 { 0.09 mM; normal, 1.97 { proximal tibial metaphysis of wild-type (///) and heterozygous (//0) mice revealed a significant reduction in trabecu-0.11 mM; each value is the mean { SEM of six determinations) and of plasma PTH (33.7 { 13.9 pg/ml; normal, 37.9 lar bone volume although the numbers of trabeculae were not significantly different. { 11.1 pg/ml; each value is the mean { SEM of six determinations).
Localization of PTHrP and the PTH/PTHrP Receptor Histological Alterations of Long Bones in Heterozygous Mice
In light of our observations documenting the existence of a haploinsufficient phenotype in heterozygous PTHrP muGiven the dysmorphic features and reduced level of PTHrP mRNA in the heterozygotes, we examined the long tants and to assess the role played by PTHrP in their skeletal localization studies were similar in both groups of animals, only the results from normal animals have been shown. Both PTHrP mRNA (Fig. 4A ) and protein ( Fig. 4B ) were expressed most intensely by plump osteoblasts on mixed spicules close to the epiphyseal plate. Flattened osteoblasts (bone lining cells) in the epiphysis and diaphysis demonstrated weaker reactivity, as did some superficial osteocytes. Osteoclasts revealed neither gene expression nor immunoreactivity for PTHrP. No reactivity was evident in sections treated with a sense probe for in situ hybridization (Fig. 4C) or with preadsorbed serum for immunocytochemistry (Fig. 4D) .
PTH/PTHrP receptor gene expression was distributed mainly in the proliferative zone of the epiphyseal growth plate, including the uppermost region of the hypertrophic zone, but not in the lower hypertrophic zone (Fig. 5A) . In bone tissue, mature osteoblasts on the bone surface and nonmarrow ''preosteoblastic'' cells (previously called PT cells by us) located in the intertrabecular region expressed mRNA encoding the PTH/PTHrP receptor (Fig. 5B) . PT cells are characterized by having minimal rough endoplasmic reticulum, many vesicles, abundant glycogen granules, and scattered Golgi apparatus (Rouleau et al., 1988 (Rouleau et al., , 1990 . A similar distribution of binding of both 125 I-labeled PTHrP and 125 I-labeled PTH to both mature osteoblasts and PT cells was observed by light microscope radioautography after in vivo injection (Fig. 5C ). Using electron microscope radioautography, iodinated ligand was found to bind to the surface of both chondrocytic and osteoblastic cell types. Double-labeled in situ hybridization for PTHrP and its is inadequate for the development of a normal phenotype. Morphologically, the defects in heterozygotes appear somewhat similar to those seen in mice homozygous for PTHrP abnormalities, we examined the distribution of both the ligand and its receptor in bone tissue from normal (///) gene ablation (Amizuka et al., 1994) , although the alterations in trabecular bone structure and the infiltration of and heterozygous (//0) animals. As the results from these is also seen mainly in osteoblasts (OB). However, a faint reaction can also be detected in some osteocytes (arrowheads) in the superficial layer of the bone matrix. No signals were observed using a sense riboprobe (C) or if the antiserum was preadsorbed with 100 mg/ml of PTHrP-(1-34) (D). All sections are counterstained with methyl green. All bars, 20 mm. the bone marrow and intertrabecular spaces by adipocytes of the hormone and perhaps the pulsatile nature of its secretion. Our studies and those of others (Lee et al., 1993 (Lee et al., , 1994 ) are skeletal abnormalities characteristic of the heterozygotes. Furthermore, the defects in homozygous animals ocnow indicate that the capacity of PTH to act in bone must also be considered in terms of its interaction with receptors cur in the fetus and result in the death of these dyschondroplastic mice at birth (Karaplis et al., 1994) . In contrast, on osteoblasts which may be occupied to a variable extent by endogenously produced PTHrP, which itself can act as the abnormalities in heterozygotes are not evident at birth and are of minor consequence at 1 and 1/2 months of age.
an autoregulatory factor. Finally, our studies may also bear on the issue of whether Such gene dosage effects, appearing at a later stage in the heterozygotes, could be explained on the basis of decreased PTH and PTHrP exert overlapping or discrete roles in modulating skeletal function. PTH has been reported to be capalevels of PTHrP in tissues at the precise site and/or at the precise time it is required (Fisher and Scambler, 1994) . It ble of modulating not only osteoblast but also chondrocyte function (Koike et al., 1990) . However, during embryogenewould therefore appear that absolute levels of PTHrP are critical for normal bone integrity not only in the fetus but sis, PTHrP and its receptor are believed to be expressed at a much earlier developmental stage than PTH (van de Stolpe also in the postnatal skeleton.
Cellular abnormalities were clearly evident in the epiphyet al., 1993) . Consequently, it is clearly PTHrP deficiency per se which is responsible for the marked developmental seal growth plate of 3-month-old heterozygous mice in which altered chondrocyte proliferation was observed. Deabnormalities observed in the fetus homozygous for PTHrP gene ablation. In that model it is difficult to determine spite retention of reasonable differentiated function, as indicated by the relatively normal distribution of type II collawhether PTH could subserve the same functional role in fetal skeletal development as PTHrP, especially inasmuch gen, chondroitin sulfate, and ALPase, the spatial organization of the growth plate was substantially altered. This as recent preliminary studies have suggested that the phenotype obtained in animals homozygous for ablation of the appeared to be the primary cause of the distorted and disorganized mixed spicules in the metaphysis of heterozygotes.
common PTH/PTHrP receptor (Lanske et al., 1994) is qualitatively similar to that occurring in animals homozygous Therefore, it is evident from the current findings that PTHrP is critically important for normal development of for PTHrP gene ablation. In the present study we have found that in animals heterozygous for PTHrP gene ablation, physthe growth plate after birth.
The presence of PTHrP and PTH/PTHrP receptors which iological concentrations of circulating PTH, although capable of maintaining normal calcium homeostasis, were unwe demonstrated in osteoblastic cells, together with the abnormalities of trabecular bone which we observed in hetable to compensate for PTHrP haploinsufficiency. Consequently, PTHrP appears to play a role distinct from PTH erozygous PTHrP-deficient animals, indicates that PTHrP also plays an essential role in osteoblast differentiation and in both growth plate cartilage and trabecular bone in the postnatal state. One possible explanation for this observathe subsequent maintenance of normal trabecular architecture. The alterations in trabecular bone and the abundance tion is that a defect in skeletal progenitor cells was caused by PTHrP deficiency in utero prior to parathyroid gland of adipocytes in the bone marrow suggest that the PTHrPdeficient heterozygote manifests a form of osteopenia. A development and only became manifest in the postnatal state. A second possibility is that circulating PTH is unable direct relationship exists between the prevalence of adipocytes in bone marrow tissue and impaired osteogenic cell to permeate and interact with skeletal receptors to which locally produced PTHrP may bind. This seems unlikely in differentiation resulting in osteopenia. Such a relationship has been reported with increasing age and in some pathologview of the fact that, as determined by radioautography, circulating PTH and PTHrP can bind to the same receptor ical states (osteoporosis) and experimental conditions (weightlessness, ovariectomy, immobilization) (Meunier et sites in vivo which have now been identified by in situ hybridization. A third possibility is that domains of the al., 1971; Jee et al., 1983; Wronski et al., 1986; Minaire et al., 1974) . This osteopenia can result not only from defective PTHrP molecule other than those shared with the PTH molecule may subserve unique functions which are imfunction of mature osteoblasts but also from a decrease in the number of osteoprogenitor cells. Given that the same portant for normal skeletal development. Further studies are required to test these possibilities. pluripotent stromal stem cells in the bone marrow compartment can give rise to adipocytes and osteoprogenitor cells (Owen, 1985) , the increased number of adipocytes in the marrow space of PTHrP heterozygous mice could be due to ACKNOWLEDGMENTS altered stem cell differentiation as a consequence of PTHrP haploinsufficiency. It becomes essential, therefore, to un- viously, the efficacy of circulating PTH in influencing bone of a scholarship from the Kidney Foundation of Canada. We thank Judith Marshall for excellent secretarial assistance and Marie Rouwas considered only in terms of the ambient concentration leau for invaluable assistance with the radioautographic studies of Jee, W. S. S., Wronski, T. J., Morey, E. R., and Kimmel, D. B. (1983) . Effects of spaceflight on trabecular bone in rats. Am. J. Physiol.
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